We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
Netflix
NFLX
$292B
| $67.5M | 0.14% |
1,955,000
+626,000
| +47% | +$20.7M |
|
152
Vulcan Materials
VMC
$36.3B
| $67.3M | 0.14% |
392,452
-375,233
| -49% | -$66.6M |
|
153
Shake Shack
SHAK
$2.3B
| $67M | 0.14% |
1,207,877
+177,997
| +17% | +$9.82M |
|
154
Deere & Co
DE
$170B
| $66.7M | 0.14% |
161,513
+119,789
| +287% | +$49.6M |
|
155
Snap
SNAP
$7.32B
| $66.5M | 0.14% |
5,933,252
+5,494,813
| +1,253% | +$57.7M |
|
156
Freshpet
FRPT
$2.83B
| $66.3M | 0.14% |
1,001,340
+425,824
| +74% | +$26.2M |
|
157
AerCap
AER
$23.9B
| $66.1M | 0.14% |
+1,175,516
| New | +$70.3M |
|
158
Johnson & Johnson
JNJ
$635B
| $64.8M | 0.14% |
417,939
-31,474
| -7% | -$5.08M |
|
159
PepsiCo
PEP
$186B
| $64.8M | 0.14% |
355,295
-536,694
| -60% | -$93.8M |
|
160
Salesforce
CRM
$134B
| $64.7M | 0.14% |
323,779
+246,344
| +318% | +$41.6M |
|
161
Phillips 66
PSX
$82.9B
| $64.5M | 0.14% |
636,689
+545,109
| +595% | +$55.4M |
|
162
GSK
GSK
$103B
| $64.4M | 0.14% |
1,809,355
+1,574,304
| +670% | +$55.1M |
|
163
Cal-Maine
CALM
$4.28B
| $64.2M | 0.14% |
1,054,021
+371,876
| +55% | +$20.7M |
|
164
Kimberly-Clark
KMB
$36.4B
| $63.8M | 0.14% |
475,522
+190,212
| +67% | +$24.7M |
|
165
Boot Barn
BOOT
$4.55B
| $63.8M | 0.14% |
832,216
-292,180
| -26% | -$22.4M |
|
166
Lockheed Martin
LMT
$134B
| $62.5M | 0.13% |
132,142
+74,204
| +128% | +$34.8M |
|
167
Ares Capital
ARCC
$13.5B
| $62.3M | 0.13% |
3,408,735
-1,127,101
| -25% | -$21.3M |
|
168
US Bancorp
USB
$99.6B
| $62.3M | 0.13% |
1,727,060
-3,296,329
| -66% | -$147M |
|
169
e.l.f. Beauty
ELF
$4.56B
| $61.1M | 0.13% |
741,506
-382,939
| -34% | -$25.8M |
|
170
Cisco
CSCO
$450B
| $60.9M | 0.13% |
1,165,614
-2,084,610
| -64% | -$102M |
|
171
Sociedad Química y Minera de Chile
SQM
$19.6B
| $60.7M | 0.13% |
749,020
+374,349
| +100% | +$32.2M |
|
172
NOV
NOV
$7.45B
| $60.2M | 0.13% |
3,254,273
+2,779,214
| +585% | +$60M |
|
173
PUT
Alphabet (Google) Class A
GOOGL
$3.91T
| $60.2M | 0.13% |
580,200
+294,900
| +103% | +$28.3M |
|
174
L3Harris
LHX
$55.9B
| $60.2M | 0.13% |
306,629
+125,262
| +69% | +$25.6M |
|
175
iShares MSCI India ETF
INDA
$6.71B
| $59.3M | 0.13% |
+1,507,358
| New | +$60.7M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.